| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3190945 | Annals of Allergy, Asthma & Immunology | 2015 | 7 Pages |
Abstract
This risk-stratification protocol for presumed carboplatin- and oxaliplatin-induced HSRs safely identifies false-negative ST reactions and nonallergic patients who can receive infusions without desensitizations. This leads to fewer unnecessary desensitizations and improved patient care.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Alberta L. MD, Sarita U. MD, Aidan A. MD, Aleena MD,